Saturday, 30 August 2014

New Novartis heart failure drug cuts risk by a fifth

BARCELONA (Reuters) - A new heart failure drug from Novartis cut the risk of both cardiovascular death and hospitalization by a fifth in a keenly awaited study, boosting hopes for a product that is seen as a multibillion-dollar seller.















via Reuters: Health News Read More Here..

No comments:

Post a Comment